First customer boards Recipharm’s soft mist inhaler technology platform
Resyca, Recipharm’s joint venture with Medspray, has boarded its first pharmaceutical customer on the soft mist inhaler (SMI) platform. An agreement has been signed involving milestones and royalties for exclusivity on the specific drug product. The innovative SMI platform consists of a portable disposable nebuliser featuring a microspray nozzle developed by spray specialist Medspray, which is designed to generate a near-monodisperse aerosol with a high lung dose. The SMI device is purely mechanical, allowing simple aqueous solutions to be used without the need for any propellants. As a